EGFR and non-small cell lung carcinoma: Complete inactivation of both RB1 and TP53 was strikingly associated with an increased risk of transformation from NSCLC to SCLC among EGFR-mutant lung adenocarcinomas, suggesting the predictive value of these two mutations in SCLC transformation [95, 96].